Daxor Corporation (DXR) Financials
DXR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 51.9 million | 23597 |
| Dec. 31, 2025 | 46.0 million | 122595 |
| June 30, 2025 | 35.9 million | 272427 |
| Dec. 31, 2024 | 36.6 million | 840296 |
DXR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.5 million | ? |
| Dec. 31, 2025 | -297470 | ? |
| June 30, 2025 | 467039 | 205214 |
| Dec. 31, 2024 | -502050 | 969888 |
DXR Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | -3.3 million |
| Dec. 31, 2025 | 9.5 million |
| June 30, 2025 | -369701 |
| Dec. 31, 2024 | 2.2 million |
DXR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 5.8 million | - | - |
| Dec. 31, 2025 | - | 112000 | - |
| June 30, 2025 | - | 262927 | - |
| Dec. 31, 2024 | - | 729966 | - |
DXR Shares Outstanding
DXR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | - | - | - |
| Dec. 31, 2025 | 4 | - | - | - |
| June 30, 2025 | 4 | - | 287847 | 205214 |
| Dec. 31, 2024 | 3 | - | 1.2 million | 969888 |
DXR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 23020 | 83347 |
| Dec. 31, 2025 | 131846 | 236481 |
| June 30, 2025 | 18348 | 78202 |
| Dec. 31, 2024 | 695307 | 74644 |
DXR
Price: $11.34
52 week price:
Earnings Per Share: 1.69 USD
P/E Ratio: 6.08
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 5100
Market Capitalization: 60.0 million